December 17, 2014 Molecular Medicine Issues 20th Anniversary Edition
Journal Focuses on the legacy and impact of Anthony Cerami’s groundbreaking work on
December 15, 2014 New Study Published In Molecular Medicine Reports That Novel Agent Decreases Neuropathic Pain in Patients with Type 2 Diabetes
December 1, 2014 Araim Pharmaceuticals Given FDA Fast Track Designation to ARA 290 for the Treatment of Sarcoidosis (Dutch Version)
October 28, 2014 Araim Pharmaceuticals Given FDA Fast Track Designation to ARA 290 for the Treatment of Sarcoidosis-associated Small Fiber Neuropathy
September 5th, 2014 The Feinstein Institute for Medical Research and Molecular Medicine announced today that it will confer the second Anthony Cerami Award in Translational Medicine to Göran K. Hansson, MD, PhD, professor of cardiovascular research at the Karolinska Institutet and head of the Cardiovascular Research Laboratory at the Center for Molecular Medicine in Stockholm, Sweden. The award is in recognition of his discoveries in atherosclerosis inflammation and cardiology.
October 10, 2013 Araim Pharmaceuticals’ ARA 290, a Peptide Engineered to Activate Innate Repair, Receives Orphan Drug Designation from the European Commission